ARCT
Price
$11.83
Change
-$0.38 (-3.11%)
Updated
Aug 7, 02:08 PM (EDT)
Capitalization
331.14M
4 days until earnings call
IDNA
Price
$21.35
Change
-$0.23 (-1.07%)
Updated
Aug 6 closing price
Net Assets
107.9M
Interact to see
Advertisement

ARCT vs IDNA

Header iconARCT vs IDNA Comparison
Open Charts ARCT vs IDNABanner chart's image
Arcturus Therapeutics Holdings
Price$11.83
Change-$0.38 (-3.11%)
Volume$1.1K
Capitalization331.14M
iShares Genomics Immnlgy & Hlthcr ETF
Price$21.35
Change-$0.23 (-1.07%)
Volume$33.8K
Net Assets107.9M
ARCT vs IDNA Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. IDNA commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and IDNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (ARCT: $12.21)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green while.

  • ARCT’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 3 TA indicator(s) are bullish.

  • ARCT’s TA Score: 3 bullish, 6 bearish.

Price Growth

ARCT (@Biotechnology) experienced а -3.63% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +8.67%, and the average quarterly price growth was +12.69%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTIDNA
RSI
ODDS (%)
N/A
Bearish Trend 14 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAUIX5.81N/A
N/A
Gabelli Utilities I
VGRTX80.66N/A
N/A
JPMorgan US Value R2
SSKEX75.85N/A
N/A
State Street Emerging Markets Eq Idx K
FESIX5.18N/A
N/A
Fidelity SAI Real Estate Index
ESAGX11.89N/A
N/A
Ashmore Emerging Markets Equity ESG A

IDNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDNA has been closely correlated with BEAM. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if IDNA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDNA
1D Price
Change %
IDNA100%
-1.06%
BEAM - IDNA
68%
Closely correlated
-2.14%
IMNM - IDNA
64%
Loosely correlated
-3.59%
ARCT - IDNA
64%
Loosely correlated
+3.21%
CRSP - IDNA
64%
Loosely correlated
+1.35%
ACLX - IDNA
63%
Loosely correlated
-1.90%
More